Presentations & Seminars
Robert S. Roscoe B.Sc.Pharm, ACPR, CDE, CPT
Clinical Collaborative Pharmacist/Certified Diabetes Educator/Medical Education Program Developer/Consultant
Owner R2 Consulting Ltd./
Independent Community Pharmacist/
Team Member Saint John Regional
Diabetes Education Center
NB Diabetes Task Force Member
Expert Committee Member/Co-Author 2013/2018 CDA CPG
4 Beach Drive, Rothesay, N.B.
cell-(506) 654-2555 (with voicemail) work- (506) 847-5557 (with voicemail)
fax- ( 506) 847-8766 home- (506) 847-0711
Presentations & Seminars |
Feb 21,2020 | Top Guns 10th Anniversary
Moncton, New Brunswick |
Diabetes Treatment and Navigating the World of Reimbursement in Making Therapeutic Choices: “Rob Has Something to Say, Pay Attention – You Can’t Afford Not to Listen
|
Family Physicians, Nurse Practitioners,
Allied Health Practitioners |
Merck Canada,
NovoNordisk Abbott Diabetes Canada |
• Differentiate various criteria for coverage
• TEACH A PERSON TO FISH rather than GIVE THEM THE FISH • Navigate criteria for complex coverage within NB • TOOLS TO GO FISHING • Appraise NB coverage related to diabetes medication, technologies and supplies • THERE COULD BE BETTER SPOTS TO FISH , BUT OURS ISN’T TOO BAD |
Jan 19,2020 | Lilly Lake Pavilion,
Saint John, New Brunswick |
Why is Diabetes Therapy changing? Cardiovascular Outcome Trials (CVOT) |
Pharmacists, Allied Healthcare Workers | Boehringer-Ingelheim | · Review of CVOT trials and its impact on Diabetes Treatments
· Review of the CardioRenal Trial results and potential impact on guidelines and Diabetes Treatment · Debate which is better SGLT-2 or GLP-1 · Review benefits and challenges of each of the classes of SGLT-2 & GLP-1 Medications |
Jan 19,2020 | Lilly Lake Pavilion,
Saint John, New Brunswick |
The LIBRE System: Overview & Reports &
|
Pharmacists, Allied Healthcare Workers | Abbott Diabetes Canada/
Boehringer-Ingelheim |
· Review of the Libre System “Nuts and Bolts”
· Demonstrate and provide “Hands On” experience with components of the LIBRE system · Troubleshoot potential problems in using the system · Review of the available Libre Reports and How to Use them |
Dec 3,2019 | Fredericton Medical Centre,
Fredericton, New Brunswick |
Effective Conversations in Diabetes: Empowering Patients to Optimize Treatment for Cardiac Protection
|
Family Physicians | Boehringer – Ingelheim | • Summarize why cardioprotective benefits are now a major consideration when choosing an anti-hyperglycemic agent for a patient with diabetes and cardiovascular disease
• Reframe conversations with patients about these medications to focus first and foremost on the cardiovascular risk-reduction benefits • Employ strategies to proactively help themselves and their patients conquer barriers (psychological, medical, social and practical) to starting and maintaining these treatments
|
Oct 2,2019 | Diabetes Canada Winnipeg,
Nova Scotia |
Updates on the Latest Research and Published Papers
|
Nurse, Nurse Practitioners,
Pharmacists, Allied HealthCare Workers |
BD Diabetes Canada | · Review and Discuss the latest published papers
· Open discussions with one of the co-authors · Discussions on updates to FIT (Forum for Injection Technique)Canada |
Sept 4,2019 | Little Louis,
Moncton, New Brunswick |
KEEP IT SIMPLE: Laying a solid foundation for long-term success with long-acting insulins
|
Pharmacist,
Allied HealthCare Practitioners |
NovoNordisk | • Recognize when a patient with type 2 diabetes is an appropriate candidate to initiate insulin therapy
• Apply key takeaways from the 2018 Diabetes Canada Clinical Practice Guidelines (CPGs) to clinical practice to successfully start basal insulin, promote patient self-titration, and conduct effective follow-up • Discuss individualization of treatment through analysis of patient and insulin characteristics, with a focus on newer long-acting analogues, as per the 2018 Diabetes Canada CPGs |
May 24,2019 | Summerside, Prince Edward Island |
Diagnosis & Treatment of Onychomycosis
|
Family Physicians | Bausch Health | • Onychomycosis etiology and diagnosis
• Urgency to treat Not just a cosmetic issue • Treatment options Oral therapies Topical therapies Canadian clinical pathway Prevention of recurrence |
April 25,2019 | Delta Fredericton,
Fredericton NB |
How to Discuss Libre Results: When You do Not have LibreView Reports
|
Large conference,
Nurse, Nurse Practitioners Allied Health Practitioners, Physicians |
Abbott Diabetes Canada | · Discuss options to review data results with your patients
· Review the different reports available · Discuss the various options on which reports and which order to use · Review using the reader/phone to review reports in real time |
April 13,2019 | Hampton Inn
Moncton,NewBrunswick |
PILLARS: Primary Care Pillars- Optimizing the Management of Diabetic Kidney Disease
|
Family Physicians, Allied Healthcare,
Pharmacists |
Janssen | • Define diabetic kidney disease (DKD) and its prevalence
• Recognize unmet needs in the management of DKD • Discuss current standards of care in the treatment of DKD and the need for new therapeutic interventions Consider the relevance of recent trials and guideline recommendations to your practice |
March 27,2019 | Little Louis,
Moncton, New Brunswick |
Diagnosis & Treatment of Onychomycosis
|
Nurse, Nurse Practitioners,
Family Physicians |
Bausch Health | • Onychomycosis etiology and diagnosis
• Urgency to treat Not just a cosmetic issue • Treatment options Oral therapies Topical therapies Canadian clinical pathway Prevention of recurrence |
March 13-15,2019 | Nationally Provided Webex/Webinar |
Insulin Injection Therapy Optimization Program (I2-TOP)
|
On Line for McKesson
Pharmacists |
montmed | · Review of Impact of Proper Injection techniques[
· Review components of FIT(Forum for Injection Technique) Canada · Identify gaps in proper injection technique and injection site rotation · Discussions around Novel products to help meet recommendations for proper injection site rotation including Coloured Needle tips |
March 12,2019 | Thandi’s Saint John
New Brunswick |
PILLARS: Primary Care Pillars- Optimizing the Management of Diabetic Kidney Disease
|
Family Physicians, Pharmacists, Allied Healthcare | Janssen | • Define diabetic kidney disease (DKD) and its prevalence
• Recognize unmet needs in the management of DKD • Discuss current standards of care in the treatment of DKD and the need for new therapeutic interventions Consider the relevance of recent trials and guideline recommendations to your practice |
Feb 12,2019 | Brit’s Saint John
New Brunswick |
CardioVascular Outcomes Trials (CVOT): Populations in the Recent Diabetes Outcome Trials: CARMELINA, CANVAS, DEVOTE, HARMONY, DECLARE, REWIND and CREDENCE
|
Family Physicians,
Speciaists |
Eli Lilly Canada | · Identify similarities and differences amongst the recent CVOT trials
· Relate the populations to the trial outcomes is it a factor or impact · Discuss the results and outcomes and the populations included · Discuss comparisons between the trials and populations studied. |
Feb 7,2019 | George Dumont Hospital
Moncton, New Brunswick |
PILLARS: Primary Care Pillars- Optimizing the Management of Diabetic Kidney Disease
|
Nurses, Allied Health care | Janssen | • Define diabetic kidney disease (DKD) and its prevalence
• Recognize unmet needs in the management of DKD • Discuss current standards of care in the treatment of DKD and the need for new therapeutic interventions • Consider the relevance of recent trials and guideline recommendations to your practice |
Dec 11,2018 | Moncton, New Brunswick |
Diagnosis & Treatment of Onychomycosis
|
Family Physicians, Allied Health,Nurses | Bausch Health/Valeant | • Onychomycosis etiology and diagnosis
• Urgency to treat Not just a cosmetic issue • Treatment options Oral therapies Topical therapies Canadian clinical pathway Prevention of recurrence |
Nov 15,2018 | Coverdale Medical Clinic Riverview,
New Brunswick |
The Next Step: Intensifying insulin therapy in patients with type 2 diabetes
|
Type | NovoNordisk | • Describe hypoglycemia in basal-insulin-treated patients with type 2 diabetes, assessing its impact on optimizing glycemic control and methods for management
• Recognize when and how to intensify glycemic control with mealtime insulin • Identify glycemic variability and how to effectively manage it • Compare new insulins available in Canada
|
Nov 6,2018 | Petitcodiac Medical Centre
Petitcodiac, New Brunswick |
In Control: Long-acting insulins for the management of type 2 diabetes
|
Family Physicians | NovoNordisk | • Establish the role of basal insulin therapy in the management of type 2 diabetes mellitus (T2DM) as per the 2018 Diabetes Canada clinical practice guidelines
• Apply strategies to overcome common challenges associated with insulin initiation and optimization and employ knowledge of key concepts, including glucose variability, hypoglycemia and continuous glucose monitoring • Compare agent-specific characteristics of the available basal insulins, with a focus on newer basal insulins |
Nov 3,2018 | Montreal Quebec |
FIT (Forum for Injection Technique) Videos
|
Video Tape Program | BD Canada/ Health Choices First | • Taking The Injection Techniques and putting it in a demonstration video
• Utilizing white board techniques to clarify those principles. |
Oct 29,2018 | Rodd Inn Miramichi
Miramichi ,New Brunswick |
KEY: Keep Educating Yourself Evidence and Diabetes Guidelines for Primary Care Physicians
|
Family Physicians, Pharmacists | Janssen | • Practical review of the 2018 Diabetes Canada Clinical Practice Guidelines
• Review the results of recent clinical studies with SGLT2 inhibitors • Use case-based scenarios to help apply and synthesize learnings |
Oct 28,2018 | Fredericton, New Brunswick |
Casting New Light on Basal Insulins: Overcoming Challenges in Diabetes Management with Next Generation Basal Insulins |
Family Physicians, Pharmacists, Allied Health Professionals | Sanofi Canada | • Describe how new basal insulin therapies allow patients to achieve safer glycemic goals
• Discuss recent clinical trial results surrounding the action profiles of longer-acting basal insulins • Recognize the differences between the available longer-acting basal insulin therapies as demonstrated by recent head-to-head clinical trial results and real-world evidence |
Oct 23,2018 | Moncton Medical Centre Moncton, New Brunswick |
KEY: Keep Educating Yourself Evidence and Diabetes Guidelines for Primary Care Physicians
|
Nurses, Allied Health Professions | Janssen | • Practical review of the 2018 Diabetes Canada Clinical Practice Guidelines
• Review the results of recent clinical studies with SGLT2 inhibitors • Use case-based scenarios to help apply and synthesize learnings |
Oct 15,2018 | Diabetes Canada Symposium
Halifax, Nova Scotia |
The Winning Edge
|
Type | BD Canada | • Review FIT 3rd Version Recommendations/Proper Injection Techniques Principles
• Review FIT Technique Plus tools for daily practice • Also provided Q & A session around injection technique |
July 17,2018 | Montreal Quebec |
3 Minute Intervention for Injection Technique
|
Video Tape
Lesson |
montmed | • Review Proper Injection Technique Principles
• Develop and Provide “Real Life 3-Minute Intervention” demonstration • Also provide Q & A session around injection technique. |
May 17,2018 | Oromocto Medical Centre |
Translating the New Evidence in the Management of Type 2 Diabetes
|
Family Physicians | AstraZeneca | • Review the impact of underlying cardiovascular disease on antihyperglycemic selection
• Examine new evidence impacting antihyperglycemic selection since the November 2016 Interim Update to the Diabetes Canada Clinical Practice Guidelines • Review the selection of antihyperglycemic medication for a patient without CVD who is not reaching glycemic targets with metformin monotherapy • Discuss the significance of CVD primary prevention results with antihyperglycemics
|
May 15,2018 | Brookside Medical Clinic Fredericton New Brunswick | Choosing DPP4i, SGLT2i, or Both,as Add-ons to Metformin: Patient Baseline Characteristics are Crucial |
Family Physicians | Merck Canada | SUMMARY:
Introduction • Glycemic management in Canada • CDA Guidelines DPP-4i or SGLT2i? • Use of baseline A1C • Monotherapy • Dual Therapy (Add-on to Metformin) • Triple therapy (Add-on to Metformin + SU) • Use of baseline eGFR • Use in the elderly Triple therapy • SGLT2i add-on to metformin + DPP-4i • DPP-4i add-on to metformin + SGLT2i • DPP-4i + SGLT2i dual add-on therapy to metformin MetaboliceffectsofDPP-4iandSGLT2i:
|
May 5,2018 | Prince Edward Island Pharmacist Annual Meeting
Charlottetown, P.E.I |
Basal Insulins: (What the Pharmacist Needs to Know)
|
Pharmacists, Allied Health Professionals | Sanofi | • Understand the current challenges with basal insulin
• Review 2 new glargine basal insulin options: • Insulin glargine 300 U/mL (Toujeo™) • Subsequent entry biologic (SEB) of insulin glargine 100 U/mL (Basaglar™) • Review insulin degludec TRESIBA • Review the Toujeo™SoloStar® injection device to ensure safety • Discuss how to initiate, transfer and monitor patients on ToujeoTM |
May 4,2018 | Day in Family Health Halifax, Nova Scotia |
Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes
|
Family Physicians | Janssen | · Evaluate the cardiorenal complications of diabetes
· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials · Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice Differentiate results from large randomized trials and real-world studies |
May 2,2018 | Moncton, New Brunswick |
BASAL INSULIN: The truth about newer basal insulin options
|
Allied Health | NovoNordisk | • Describe challenges, such as hypoglycemia, associated with basal insulin initiation and optimization
• Evaluate the pharmacokinetics, safety and efficacy of new basal insulins, and identify differentiating benefits • Discuss mechanisms to simplify basal insulin initiation and optimization
|
April 26,2018 | Bathurst, New Brunswick |
Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes
|
Family Physicians ,Allied Healthcare | Janssen | · Evaluate the cardiorenal complications of diabetes
· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials · Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice · Differentiate results from large randomized trials and real-world studies |
March 28,2018 | Rexton Medical Centre
Rexton, New Brunswick |
Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes
|
Family Physicians | Janssen | · Evaluate the cardiorenal complications of diabetes
· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials · Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice · Differentiate results from large randomized trials and real world studies |
March 26,2018 | Moncton City Hospital Moncton, New Brunswick |
Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes
|
Family Physicians, Nurses, Physicians | Janssen | · Evaluate the cardiorenal complications of diabetes
· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials · Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice · Differentiate results from large randomized trials and real world studies |
Feb 13,2018 | Brookside Medical Centre Fredericton NB | The HCP’s Guide to the Galaxy of
CVOTs and GLP-1RAs |
Family Physicians, Nurses | NovoNordisk | • •Summarize the results of contemporary CV outcome trials in type 2 diabetes, with a focus on practice-changing outcomes•
•Reflect on specific patient and agent characteristics and how to optimize T2D management using the evolving GLP-1RA class• •Discuss how to integrate GLP-1RAs into practice, based on the Diabetes Canada guidelines |
Dec 7, 2017 | Base Gagetown, New Brunswick | The HCP’s Guide to the Galaxy of
CVOTs and GLP-1RAs |
Family Physicians, Nurse Practitioners,
Allied Health Practitioners |
NovoNordisk | •Summarize the results of contemporary CV outcome trials in type 2 diabetes, with a focus on practice-changing outcomes•
•Reflect on specific patient and agent characteristics and how to optimize T2D management using the evolving GLP-1RA class• •Discuss how to integrate GLP-1RAs into practice, based on the Diabetes Canada guidelines |
Nov 30,2017 | Oromocto, New Brunswick | The HCP’s Guide to the Galaxy of
CVOTs and GLP-1RAs |
Family Physicians, Nurse Practitioners,
Allied Health Practitioners |
NovoNordisk | •Summarize the results of contemporary CV outcome trials in type 2 diabetes, with a focus on practice-changing outcomes•
•Reflect on specific patient and agent characteristics and how to optimize T2D management using the evolving GLP-1RA class• •Discuss how to integrate GLP-1RAs into practice, based on the Diabetes Canada guidelines
|
Nov 7,2017 | Moncton, New Brunswick | The Pharmacist’s Role in Interconnected Diabetes Care
Engaging Patients and Growing Your Pharmacy Business
|
Pharmacists, Nurse Practitioners , Allied Healthcare | Ascensia Diabetes | · Identify recent improvements in glucose monitoring technology and connected devices and determine the most appropriate glucose monitoring device for your patients |
· Learn how to optimize and seamlessly implement diabetes digital health monitoring into your pharmacy workflow to drive patient adherence
Utilize a case study to help build a management plan for your diabetes patients including nutrition, activity, monitoring, and follow-ups
Identify key areas to leverage the Expanded Scope of Practice (includes case discussion of Business Model canvas)
Oct 25,2017 | Mirimachi, New Brunswick | The Pharmacist’s Role in Interconnected Diabetes Care
Engaging Patients and Growing Your Pharmacy Business
|
Pharmacists, Nurse Practitioners , Allied Healthcare | Ascensia Diabetes | · Identify recent improvements in glucose monitoring technology and connected devices and determine the most appropriate glucose monitoring device for your patients |
· Learn how to optimize and seamlessly implement diabetes digital health monitoring into your pharmacy workflow to drive patient adherence
Utilize a case study to help build a management plan for your diabetes patients including nutrition, activity, monitoring, and follow-ups
Identify key areas to leverage the Expanded Scope of Practice (includes case discussion of Business Model canvas)
Oct 17,2107 | Fredericton, New Brunswick |
“Real World Evidence im Basal Insulin Therapy”
|
Family Physicians, Nurse Practitioners,
Pharmacists
|
Sanofi | •To assess the clinical characteristics and outcomes of patients with T2D who transferred to Gla-300 from other basal insulin analogs in the US.
•To evaluate real-word hypoglycemia risk and clinical outcomes in patients with T2D who had been receiving treatment with basal insulin and transferred to Gla-300 •To compare changes in clinical measures before and after initiation and dosage of Gla-100 and Gla-300 in insulin-naïve patients with T2D in a real-world setting •To evaluate clinical outcomes of patients with T2D using basal insulin who were transferred to either Gla-300 or other basal insulins in real-world clinical practice |
Sept 20,2017 | Fredericton, New Brunswick | The Pharmacist’s Role in Interconnected Diabetes Care
Engaging Patients and Growing Your Pharmacy Business
|
Pharmacists, Nurse Practitioners , Allied Healthcare | Ascensia Diabetes | · Identify recent improvements in glucose monitoring technology and connected devices and determine the most appropriate glucose monitoring device for your patients |
· Learn how to optimize and seamlessly implement diabetes digital health monitoring into your pharmacy workflow to drive patient adherence
Utilize a case study to help build a management plan for your diabetes patients including nutrition, activity, monitoring, and follow-ups
Identify key areas to leverage the Expanded Scope of Practice (includes case discussion of Business Model canvas)
June 27,2017 | Shediac New Brunswick |
1,2,3 Go!
|
Family Physicians, Nurse Practitioners | Janssen | •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)
•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease •Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events in patients with T2DM (hypoglycemia, SADMANS…) |
June 21,2017 | Elmsdale Clinic New Brunswick |
1,23, Go!
|
PrimaryCare Physicians | Janssen | •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)
•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease •Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events in patients with T2DM (hypoglycemia, SADMANS…) |
June 20,2017 | LIVE WEBNAR Provider |
Evolution of mealtime control: Advancements towards a physiologic profile
|
On Line Presentation Allied Healthcare Providers | NovoNordisk | •Identify approaches to address challenges in mealtime insulin management.
•Describe the pathophysiology of postprandial hyperglycemia in diabetes. •Explore the rationale and applicability of rapid-acting insulin analogues in type 1 and type 2 diabetes
|
June 14,2017 | Moncton Hospital, New Brunswick | 1,2,3 Go!
|
Atlantic Meeting of Shoppers Drug Mart | Jannsen | •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)
•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease •Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events in patients with T2DM (hypoglycemia, SADMANS…) |
April 26,2017 | Oromocto, New Brunswick | 1,2,2 Go !
|
Primary Care Physicians, Nurse Practritrioners | Janssen | •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)
•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease •Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events in patients with T2DM (hypoglycemia, SADMANS…)
|
Feb 4,2017 | Moncton,New Brunswick | “Navigating the Complex World of Coverage and Patient Access”
|
Primary Care Physicians, Nurse Practitioners | Top Guns Planning Committee | · Review of CDA CPG 2016 update A1c treatment goals
· Review of the CDA CPG 2016 pharmacological management 2016 update · Discuss the various coverage options for patients from different backgrounds and insurance coverages · Discuss the various treatment barriers and potential approaches to facilitate quick and efficient methods in obtaining approvals |
Dec 8,2016 | Riverside-Albert Medical Clinic |
CVOT’s: Getting to the Heart of the Matter
|
Primary Care Physicians, Nurse practitioners, general nursing | NovoNordisk | General review of cardiovascular risk in patients with diabetes and reviewing briefly older trials, then leading to the latest CVOT LEADER, SUSTAIN, Empa-REG, and review the results then discussion using case studies on where these agents may be best utilized based on the evidence. |
Nov 2,2016 | Saint John Regional Hospital, Saint John New Brunswick |
Subsequent Entry Biologics (SEB): A New option in Insulin Therapy
|
Diabetes Education Centre, Nurse CDE, Medical students | Eli Lilly Canada | · Differentiate SEBs from a manufacturing and a regulatory perspective;
· Explain the differences between subsequent entry biologic (SEB) · Describe the safety and efficacy of SEB insulin · Identify the clinical implications surrounding the arrival of SEB insulin |
Oct 22/23,2016 | Toronto, Ontario |
Diabetes Gadgets & Gizmos: Helping patients select, start, and succeed with diabetes devices
|
Pharmacists & Pharmacists CDE ‘s | API (Allied Pharmacists Inc.)
|
Multiple presentation provided utilizing Ppt. and interactive sessions with the following learning objectives:
• Recognize the role that diabetes devices play in enhancing patient self-management • Compare and contrast available diabetes devices and explain key features and benefits • Select the most suitable devices to individualize diabetes care based on patient characteristics and management goals |
OCT 20,2016 | Moncton New Brunswick |
The Pharmacist’s Role in the |
Pharmacy Owners, Pharmacists, Pharmacist CDE’s | Janssen, Johnson & Johnson |
|
October 6,2016 | Tracadie, New Brunswick | EVOLUTION OF TYPE 2 DIABETES MANAGEMENT
|
Nurse Practitioners Annual General Meeting | Merck Canada | · Differentiate between non-insulin options for patients not at A1C target
· Appraise and interpret data emerging from large T2DM CV safety trials · Personalize glucose-lowering therapy according to patient characteristics and CV risk profile |
September 27,2016 | Fredericton, New Brunswick |
Basal Insulins:
|
Pharmacist CDE’s | Sanofi Canada | • Understand the current challenges with basal insulin
• Review 2 new glargine basal insulin options: – Insulin glargine 300 U/mL (Toujeo™) – Subsequent entry biologic (SEB) of insulin glargine 100 U/mL (Basaglar™) • Review the Toujeo™ SoloStar® injection device to ensure safety • Discuss how to initiate, transfer and monitor patients on ToujeoTM |
Sept 21,2016 | Minto, New Brunswick | Finding the Key to Individualizing Treatment in Type 2 Diabetes
|
Nurse Practitioner Regional Diabetes Training | Astra Zeneca | · Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications
· Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors · Distinguish the role of newer pharmacological agents as add-on therapies to metformin |
June 22,2016 | Halifax, Nova Scotia |
Injectable Therapies: Oh the challenges!! , Too Many Choices –How do we choose? Just whose job is it anyway?
|
Professional Sales Staff | Astra Zeneca | · Update and discussions surrounding Injectable therapies for Diabetes
· Identify the differences between the products and discuss how they may be positioned. · Discussion on the new agents available: coverage, how do we choose, where does it fit · Discussion on the who has the best role in educating the patient on their options. · Discussion on who is best suited to do the injectable training. |
June 10,2016 | Moncton, New Brunswick | Managing Your Patients with Onychomycosis: “I am Embarrassed to Take my Shoes Off”
|
Canadian Federation of Podiatry Medicine National Convention. | Valeant Pharmaceuticals | · Assess a patient presenting with common signs and symptoms of onychomycosis
· Review a patient for factors that increase the risk of onychomycosis infection · Counsel a patient on the goals of treatment and expectations of pharmacotherapy · Determine the role for systemic or topical therapy in the management of onychomycosis · Educate a patient on strategies to reduce their risk of onychomycosis or a recurrence of the infection |
May 26,2016 | WEBNAR | Diabetes Management : From Head to Toe
|
Open attendance to the province. CDE, Dietitians, Nurse, Pharmacists, etc | Valeant Pharmaceuticals | This Live WEBNAR offered 3 main topics:
· The role of compliance and improving outcomes: are the Extended Release products a better choice in some patients? · The evolving role of Lodalis (Colesevelam) in managing the diabetes patient who also is not at goal with their lipid targets · The Increased incidence of Onychomycosis in Diabetes, the increased risk of complications due to Onychomycosis, and what are the treatment options available , and how to use them. |
May 6,2016 | Fredericton ,New Brunswick |
Finding the Key to Individualizing Treatment in Type 2 Diabetes
|
Community Health Centre Professional Staff Education Meeting, Nurse, Nurse Practitioner, Physicians.
Practical Nurses |
Astra Zeneca | · Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications
· Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors · Distinguish the role of newer pharmacological agents as add-on therapies to metformin
|
March 29,2016 | Hillside Medical Centre
Fredericton, New Brunswick |
New CDA Clinical Practice Guideline Interim Update and Finding the Key to Individualizing Treatment in Type 2 Diabetes
|
Primary Care physicians, Medical students, staff nurses | Astra Zeneca | · Update Program and inform participants of the Treatment Algorithm update that occurred 24 hours earlier
· Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications · Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors · Distinguish the role of newer pharmacological agents as add-on therapies to metformin |
March 10,2016 | Saint John, New Brunswick |
Pharmacy Practice Pilot Presentation
|
Pharmacists & Pharmacist CDE’s +
Pharmacy Students |
Sanofi | • Understand the current challenges with basal insulin
• Review 2 new glargine basal insulin options: • Insulin glargine 300 U/mL (Toujeo™) and Biosimilar of insulin glargine 100 U/mL (Basaglar™) • Review the injection device to ensure safety • Discuss how to initiate, transfer and monitor patients on ToujeoTM |
Feb 19,2016 | LIVE WEBNAR |
“I am Embarrassed to Take my Shoes Off” : Managing your Patients with Onychomycosis
|
Open attendance to the province. CDE, Dietitians, Nurse, Pharmacists, etc. | Valeant | · Assess a patient presenting with common signs and symptoms of onychomycosis
· Review a patient for factors that increase the risk of onychomycosis infection · Counsel a patient on the goals of treatment and expectations of pharmacotherapy · Determine the role for systemic or topical therapy in the management of onychomycosis · Educate a patient on strategies to reduce their risk of onychomycosis or a recurrence of the infection |
Feb 11,2016 | Auberge le Vieux Presbytere de Bouctouche
|
Finding the Key to Individualizing Treatment in Type 2 Diabetes
|
Primary Care Physicians Area Group Mtg. | Astra Zeneca | · Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications
· Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors · Distinguish the role of newer pharmacological agents as add-on therapies to metformin |
Jan 26,2016 | Moncton/Dieppe Podiatric Diabetes & care Centre |
INSIDE INSULIN PUMPS: A comparison of rapid-acting insulin analogues |
Teaching Staff at the Diabetes Centre. Physicians, Nurse Practitioners, Nurse CDE’s | NovoNordisk | Topics were arranged by request and included:
• STABILITY OF RAIA IN CSII:IN VITRO STUDIES • Clinical trials comparing RAIA in CSII • CSII is based on a continuous infusion of insulin via an external pump, addressing both basal and prandial requirements1 • CSII allows administration of insulin that closely mimics physiological secretion of insulin2 • Properties of a ideal rapid-acting insulin analogue for optimal use in CSII include3: • Rapid-action • Soluble • Uniform absorption characteristic |
Feb 19,2106 | Fredericton, New Brunswick |
New Advances in Insulin Therapy
|
Pharmacists with interest in Diabetes & Pharmacist CDE | Sanofi | • Provide guidance and support to family members and patients living with type 2 diabetes (T2D);
• Describe the current challenges with insulin use and desired properties of new insulins; • Define what a biosimilar is and introduce the clinical profile of biosimilar glargine (LY2963016); • Review key clinical outcomes from long-acting basal insulins recently approved and in development; • Explain the rationale and benefits of the fixed combination of basal insulin and GLP-1 receptor agonist therapy in the management of T2D; and • Describe key clinical trial outcomes from two upcoming bolus insulin therapies.
|
Dec 18,2015 | Saint John | Finding the Key to Individualizing Treatment in Type 2 Diabetes
|
Nurse Practitioners | Astra Zeneca | · Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications
· Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors · Distinguish the role of newer pharmacological agents as add-on therapies to metformin
|
November 25,2015 | Moncton, New Brunswick |
Finding the Key to Individualizing Treatment in Type 2 Diabetes
|
Aboriginal Diabetes Initiative Atlantic Meetings | Astra Zeneca | · Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications
· Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors · Distinguish the role of newer pharmacological agents as add-on therapies to metformin
|
Aug 10,2015 | Oulton College Moncton, New Brunswick |
Diabetes Gadgets & Gizmos: Helping patients select, start, and succeed with diabetes devices |
Pharmacy Technician Class | NovoNordisk | Multiple presentation provided utilizing Ppt. and interactive sessions with the following learning objectives:
• Recognize the role that diabetes devices play in enhancing patient self-management • Compare and contrast available diabetes devices and explain key features and benefits • Select the most suitable devices to individualize diabetes care based on patient characteristics and management goals |
June 11,2105 | Saint John, New Brunswick |
How to Initiate the Insulin Conversation With Your Patients |
Dispensing Pharmacists, Pharmacist CDE’s | Bayer HealthCare |
|
May 29,2016 | Ottawa, Ontario |
O.P.T.I.O.N.S |
Canadian Pharmacists Annual Convention | Canadian Pharmacists Association/Pfizer | Overview of the style clinics that I am providing to Primary Care Offices:
· Discussion on how they started, how they are evolving, possible future steps. · Presented a typical process of a clinic · Answered Questions as par of a panel once project was presented |
May 23, 2016 | Fredericton New Brunswick |
The Role of the Kidneys in Diabetes Control: Focus on SGLT2 Inhibitors-Concept and Questions
|
New Brunswick Pharmacists Annual Convention | Janssen | • Describe the mechanism for the reabsorption of glucose in the kidneys;
• Describe the SGLT2 inhibitors (sodium/glucose cotransporter 2), their mode of action and pharmacodynamic effects; • Discuss the potential role of SGLT2 inhibitors in the treatment of type 2 diabetes.
|
May 23,2015 | Fredericton New Brunswick |
Medtronic Diabetes Updates
|
New Brunswick Diabetes Educators Annual Meeting | Medtronic/Bayer HealthCare | Variety of a series of general updates on:
· Insulin Pumps · New Blood Glucose Meters · New Therapies available · General discussions within the group of 50 + participants |
April 10,2016 | Live WEBINAR |
Glumetza – where does it fit in diabetes management? Lodalis – where does it fit in the diabetic hypercholesterolemia comorbidity patient?
|
Open to all Diabetes Educators and Diabetes Centres in New Brunswick | Valeant Pharmaceuticals | · The role of compliance and improving outcomes : are the Extended Release products a better choice in some patients.
|
Feb 27,2016 | Halifax, Nova Scotia |
“Hands On” Diabetes |
Primary Care Physicians | B/D Canada | • Troubleshoot the practical aspects of insulin injection with suboptimal glycemic control on insulin (injection technique, site complications)
• Assess for and manage lipohypertrophy • Perform a proper foot exam, including the use of a monofilament to detect neuropathy |
Feb 28,2015 | Live Webinar/Webex |
“ Unique Therapeutic Agents for Diabetes and Your “Cholestabetes” Patient” |
CDE Nurse, Dietitians, Pharmacists | Valeant Pharmaceuticals | · Discussing the role of Colesevelam in the management of Hypercholesteremia when statins are not enough especially in the Diabetes population.
· Discussion of novel therapeutic approaches to management of Diabetes especially when Metformin is resulting in tolerance issues. Role of Extended Release Metformin · How these therapeutic agents work, where might they fit in the continuum of treatment, where should they not be used, proper dosing and usage information |
Feb 28,2015 | Dartmouth Nova Scotia |
“ Hands on Diabetes” |
Primary Care physicians as part of Accredited disease Updates | BD Healthcare | · Troubleshoot the practical aspects of insulin injection with sub-optimal glycemic control. Emphasis on insulin/injection technique & site complications.
· Assess for and manage Lipohypertrophy · Perform a proper foot exam, including the use of a monofilament to detect and screen for neuropathy. |
Feb 9,2015 | Toronto Ontario |
FIT Forum for Injection Technique Canada: Recommendation for Best Practice In Inj- 2nd EDITION Updates and What’s new /Changed. |
CDE Pharmacists | BD Healthcare | As indicated by the title review of the FIT Injection Recommendations as a review of what was updated from the previous edition, challenges presented with the first edition and new information that resulted from these questions, New sections on GLP-1’s (Incretin therapies) , and updates on existing sections provided. A review of the recommendations as well provided identifying where the document has been updated, and what has changed. |
Nov 6,2014 | Hamilton Ontario |
Motivational Interviewing: Getting to the point
|
Ontario Nurse Practitioner Annual AGM & Conference | Antibody Commnications
NovoNordisk Canada |
The program will help enable the attendees to:
· Recognize challenges faced by healthcare providers (HCPs) in the recommendation and initiation of injectable therapies in diabetes management
|
Nov 1,2014 | Halifax, Nova Scotia |
Evolution of a Retail Pharmacy Practice
|
College of Pharmacy Address | R-2 Consulting Ltd | · Delivered the evolution of how my practice stepped up from dispensing to now practicing within a variety of physicians offices.
· How I started , what went wrong- what really worked, role of mentorships, what next steps I see for the graduates, discussions around their point of view . |
Oct 8,2014 | Saint John, New Brunswick | Southern New Brunswick Pharmacist CDE Group Meeting
|
Pharmacist CDE CME | Sanofi | · Presented the approach of the Basal + approach of additional insulin therapy comparing it to other insulin advancement therapies.
· Facilitated the delivery of discussions around the expanded role of pharmacists, tools that work, experience around the communication with other healthcare professionals, taking it to the next level. |
Oct 2-3,2014 | Gander, Newfoundland | Talk of the Town SGLT-2’s
|
CDE Certified Diabetes Educators Central /Provincial Conference | Janssen | · Describe the glucose reabsorption mechanism in the kidney;
· Explain the SGLT2 inhibitors, their pharmacodynamics effects and their role in Type 2 diabetes; · Discuss the indications and appropriate clinical applications of canagliflozin, the first in the SGLT2 inhibitor class for Type 2 diabetes management. |
June 9-11,2014 | Saint John’s, Newfoundland
|
Feel IT, Try IT, Switch IT” Exploring Lipohypertrophy & Benefits of proper Injection Technique UPDATED VERSION
|
Pharmacist CME
|
BayerHealthcare/ BD Healthcare | Description: Upon completion of this continuing professional development program, participants will be better able to:
Feel IT
• Understand what lipohypertrophy is, how it develops and how to prevent it. • Learn how you can assess and identify lipohypertrophy (lipos) in your practice. • Review practical tips for treatment of lipohypertrophy.
Try IT
• Review proper injection technique (IT) for people living with diabetes, including proper site rotation.
Switch IT
• Understand the impact of needle length in relation to lipohypertrophy.
|
May 23,2014 | Moncton, New Brunswick | Beyond Metformin, Navigating The Treatment Continuum For Your Patients With Type 2 Diabetes |
Pharmacist CDE | NovoNordisk | Description: Upon completion of this continuing professional development program, participants will be better able to:
• Recognize the rationale for timely initiation and intensification of treatment to achieve glycemic targets • Understand how currently available treatment options compare with respect to key challenges in diabetes management: A1C, weight and hypoglycemia • Implement effective strategies to help patients and health practitioners overcome barriers to treatment at various stages of the treatment continuum • Recognize importance of establishing individualized targets (i.e., A1C, weight) based on patient characteristics
|
May 14,2014 | Saint John, New Brunswick
|
Feel IT, Try IT, Switch IT” Exploring Lipohypertrophy & Benefits of proper Injection Technique UPDATED VERSION
|
Pharmacist CME
|
Bayer Healthcare/ BD Healthcare | Description: Upon completion of this continuing professional development program, participants will be better able to:
Feel IT
• Understand what lipohypertrophy is, how it develops and how to prevent it. • Learn how you can assess and identify lipohypertrophy (lipos) in your practice. • Review practical tips for treatment of lipohypertrophy.
Try IT
• Review proper injection technique (IT) for people living with diabetes, including proper site rotation.
Switch IT
• Understand the impact of needle length in relation to lipohypertrophy.
|
May 1, 2014 | Vancouver, British Columbia | It’s a Good Time to talk About Insulin.
“ So Why is This Not Happening”
|
Pharmacist CME
|
Sponsor: BD Healthcare, WalMart Canada Corporate | Description: Upon completion of this continuing professional development program, participants will be better able to:
• Understand the concept of clinician inertia regarding starting insulin for Type 2 Diabetes. • Understanding the benefits of early insulinization for Type 2 Diabetes and become familiar with strategies to overcome barriers to initiating discussions of insulin with those with Type 2 Diabetes. • Understand the concept of psychological insulin resistance (PIR) in patients with Type 2 diabetes and become familiar with how to assess PIR in those living with Type 2 Diabetes. · Become familiar with change interventions using motivational interviewing, cognitive restructuring and fear management |
April 25,2014 | Fredericton, New Brunswick |
Feel It, etc,
|
Physician/
Nurse Practitioner/ Dietitian Pharmacist CME (Multidisciplinary Healthcare Provider Presentation |
B/D Healthcare | Description: Upon completion of this continuing professional development program, participants will be better able to:
Feel IT
• Understand what lipohypertrophy is, how it develops and how to prevent it. • Learn how you can assess and identify lipohypertrophy (lipos) in your practice. • Review practical tips for treatment of lipohypertrophy.
Try IT
• Review proper injection technique (IT) for people living with diabetes, including proper site rotation.
Switch IT
• Understand the impact of needle length in relation to lipohypertrophy.
|
April 25,2014 | Fredericton, New Brunswick |
SGLT-2 The New Kid on the Block
|
Physician/
Nurse Practitioner/ Dietitian Pharmacist CME (Multidisciplinary Healthcare Provider Presentation |
Jannsen | · Describe the glucose reabsorption mechanism in the kidney;
· Explain the SGLT2 inhibitors, their pharmacodynamic effects and their role in Type 2 diabetes; · Discuss the indications and appropriate clinical applications of canagliflozin, the first in the SGLT2 inhibitor class for Type 2 diabetes management.
|
April 24,2014 | Fredericton, New Brunswick |
Insulin Academy
|
Physician/
Nurse Practitioner/ Dietitian Pharmacist CME (Multidisciplinary Healthcare Provider Presentation |
NovoNordisk | By the end of this program, participants will be able to:
• Identify when T2DM patients need to start insulin therapy • Implement simple strategies for starting insulin • Identify T2DM patients currently on basal insulin therapy that need mealtime insulin • Implement simple strategies to add and adjust mealtime insulin
|
April 4, 2014 | Toronto, Ontario | It’s a Good Time to talk About Insulin.
“ So Why is This Not Happening”
|
Pharmacist CME
|
Sponsor: BD Healthcare, WalMart Canada Corporate | Description: Upon completion of this continuing professional development program, participants will be better able to:
• Understand the concept of clinician inertia regarding starting insulin for Type 2 Diabetes. • Understanding the benefits of early insulinization for Type 2 Diabetes and become familiar with strategies to overcome barriers to initiating discussions of insulin with those with Type 2 Diabetes. • Understand the concept of psychological insulin resistance (PIR) in patients with Type 2 diabetes and become familiar with how to assess PIR in those living with Type 2 Diabetes. · Become familiar with change interventions using motivational interviewing, cognitive restructuring and fear management |
April 2,2014 | Moncton, New Brunswick | “Feel IT, Try IT, Switch IT”
Exploring Lipohypertrophy & Benefits of proper Injection Technique UPDATED VERSION
|
Pharmacist CME
|
Sponsor: BD HealthCare, Lilly Canada,
Bayer Healthcare |
Description: Upon completion of this continuing professional development program, participants will be better able to:
Feel IT
• Understand what lipohypertrophy is, how it develops and how to prevent it. • Learn how you can assess and identify lipohypertrophy (lipos) in your practice. • Review practical tips for treatment of lipohypertrophy.
Try IT
• Review proper injection technique (IT) for people living with diabetes, including proper site rotation.
Switch IT
• Understand the impact of needle length in relation to lipohypertrophy.
|
Feb 25,2014 | Sussex, New Brunswick | Beyond Metformin, Navigating The Treatment Continuum For Your Patients With Type 2 Diabetes |
Physician, Family Practice CME
|
Sponsor: NovoNordisk Canada | Description: Upon completion of this continuing professional development program, participants will be better able to:
• Recognize the rationale for timely initiation and intensification of treatment to achieve glycemic targets • Understand how currently available treatment options compare with respect to key challenges in diabetes management: A1C, weight and hypoglycemia • Implement effective strategies to help patients and health practitioners overcome barriers to treatment at various stages of the treatment continuum • Recognize importance of establishing individualized targets (i.e., A1C, weight) based on patient characteristics
|
January 30,2014 | Toronto, Ontario | “Feel IT, Try IT, Switch IT”
Exploring Lipohypertrophy & Benefits of proper Injection Technique UPDATED VERSION
|
Pharmacist CME
|
Sponsor: BD HealthCare, Metropolitan Toronto Pharmacists Association
(MTPA) |
Description: Upon completion of this continuing professional development program, participants will be better able to:
Feel IT
• Understand what lipohypertrophy is, how it develops and how to prevent it. • Learn how you can assess and identify lipohypertrophy (lipos) in your practice. • Review practical tips for treatment of lipohypertrophy.
Try IT
• Review proper injection technique (IT) for people living with diabetes, including proper site rotation.
Switch IT
• Understand the impact of needle length in relation to lipohypertrophy.
|
Nov 3, 2013 | Halifax, Nova Scotia | INCRETIN THERAPIES: THEY’RE HERE,NOW WHAT?
Answering your most frequently asked questions
|
Pharmacist CME
|
Sponsor: PANS (Pharmacy Association of Nova Scotia) | Description: Upon completion of this continuing professional development program, participants will be better able to:
• Understand the two classes of incretin agents and their mode of action • Differentiate between GLP-1 receptor agonists and DPP-4 inhibitors • Review the efficacy and safety data of currently available incretin agents and where they fit in the 2013 CDA guidelines • Explain how to optimally incorporate incretin therapies into clinical practice and to discuss the rationale for a personalized evidence-based approach to care
|
Oct 18, 2013 | Montreal, Quebec | Diabetes Painful NEUROPATHY: A Pharmacy Case
|
National Diabetes/ Vascular Convention
(Vascular 2013) |
Sponsor: Canadian Diabetes Association (CDA) | As lead author provided a case based presentation providing participants kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communications forms to relay information on other healthcare professionals. PowerPoint, Q&A, Interactive Case Discussion
Description: Upon completion of this continuing professional development program, participants will be better able to: • List the signs, symptoms, and risk factors for developing DPN • Screen for DPN as part of routine management of diabetes and its co-morbidities • Apply tools to counsel the patient on evidence-based treatment options for painful DPN, and follow up with appropriate interventions • Discuss the basic concepts of good foot care to prevent and screen for diabetes foot complications
|
Oct 10, 2013 | Rothesay, New Brunswick | INCRETIN THERAPIES: THEY’RE HERE,NOW WHAT?
Answering your most frequently asked questions
|
Physician/
Nurse Practitioner/ Dietitian Pharmacist CME (Multidisciplinary Healthcare Provider Presentation)
|
Sponsor: Novo Nordisk Canada | Description: Upon completion of this continuing professional development program, participants will be better able to:
• Understand the two classes of incretin agents and their mode of action • Differentiate between GLP-1 receptor agonists and DPP-4 inhibitors • Review the efficacy and safety data of currently available incretin agents and where they fit in the 2013 CDA guidelines • Explain how to optimally incorporate incretin therapies into clinical practice and to discuss the rationale for a personalized evidence-based approach to care
|
Oct 5, 2013 | Moncton, New Brunswick | Canadian Diabetes Association 2013 Clinical Practice Guidelines Update
|
Pharmacist CME
|
Sponsor: Canadian Cardiovascular Pharmacists Network | Description: As a result of attending this educational session the following objectives will be met:
• Familiar with most major changes within the 2013 CDA clinical practice guidelines • Able to apply the recommendations in clinical practice and be familiar with online resources.
|
June 3, 2013 | Charlottetown, Prince Edward Island |
Diabetic Peripheral Neuropathy: The Diabetic Foot A Pharmacists Role
|
National Annual Convention | Sponsor: Canadian Pharmacists Association | As lead author provided a case based presentation providing participants kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communications forms to relay information on other healthcare professionals. PowerPoint, Q&A, Interactive Case Discussion
Description Upon completion of this continuing professional development program, participants will be better able to: • List the signs, symptoms, and risk factors for developing DPN • Screen for DPN as part of routine management of diabetes and its co-morbidities • Apply tools to counsel the patient on evidence-based treatment options for painful DPN, and follow up with appropriate interventions • Discuss the basic concepts of good foot care to prevent and screen for diabetes foot complications
|
June 1, 2013 | Charlottetown, Prince Edward Island | Advancing Pharmacy Practice in Diabetes |
National Annual Convention | Sponsor: Canadian Pharmacists Association | I was responsible for developing and delivering this one-day interactive workshop providing useful learning and sharing that can be put into practice right away. Topics included lab tests that help assess patient status and individualize therapy; when patients should self-monitor and using pattern management to optimize treatment; promoting lifestyle and nutrition; current evidence on oral agents; managing insulin starts, FIT recommendations for injection technique; the importance of hypoglycemia and lowering the risk from initial screening to long-term complications. Participants will have access to practice and screening tools to use in their pharmacy practice. This workshop is a component of the Diabetes Strategy for Pharmacists and was developed with funding from the Public Health Agency of Canada under the Canadian Diabetes Strategy.
|
May 28, 2013 | Halifax, Nova Scotia | FEEL IT, TRY IT, SWITCH IT – Exploring Lipohypertrophy & Benefits of Proper Injection Technique |
Pharmacist CME
|
Sponsor: BD Healthcare, Bayer Healthcare, Lilly Canada | Description: As a result of attending this educational (1.5 CE’s) evening the following objectives will be met:
• Understand what lipohypertrophy is, how it develops and how to prevent it • Learn how you can assess and identify lipohypertrophy (lipos) • Review practical tips for treatment of lipohypertrophy • Review proper injection technique (IT) for people living with diabetes, including proper site rotation • Understand the impact of needle length in relation to lipohypertrophy
|
May 25, 2013 | Fredericton, New Brunswick |
Innovations in Anaphylaxis: Diagnosis, Treatment, and Management of Anaphylaxis
|
Annual Provincial Pharmacists Convention | Sponsor: Sanofi Canada | Description: PowerPoint presentation, Lecture, Q&A over 60 minutes. After participating in the following educational program participants should be able to:
The treatment options are provided with “hands-on” practice including the newer devices and comparisons between each are provided discussing both potential advantages of each device style as well as potential concerns as discussed during presentation. |
May 25, 2013 | Fredericton, New Brunswick |
Monitoring with Purpose: Blood Glucose Pattern Management
|
Annual Provincial Pharmacists Convention | Sponsor: Sanofi Canada | Description: PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. The presentation demonstrates utilizing a new tool that organizes blood glucose values to identify patterns and how to analyze and respond to these patterns. The cases include identifying when to add a second/third agent, hypoglycaemia, starting basal insulin, and using or needing to adjust diet therapy. |
May 22, 2013 | Sydney, Nova Scotia |
Incretins: Addressing the Multifactorial Nature of Type 2 Diabetes
|
Multidisciplinary
Healthcare Professional CME |
Sponsor: Novo Nordisk | PowerPoint and case based interactive program This 60-minute presentation will visit the newer class of agents: The Incretin based therapies. The talk will explore the difference between the 2 classes of medications within this newer class of therapies; the DPP-IV inhibitors and the GLP-1 Agonists. Considerations of incretin effects on other risk factors will be discussed. Also on the presentation agenda is the discussion of ways to support patients in overcoming the injection barrier to achieve effective management of type 2 diabetes |
May 22,2013 | Antigonish, Nova Scotia |
Incretins: Addressing the Multifactorial Nature of Type 2 Diabetes
|
Pharmacist CE | Sponsor: Novo Nordisk | PowerPoint and case based interactive program This 60-minute presentation will visit the newer class of agents: The Incretin based therapies. The talk will explore the difference between the 2 classes of medications within this newer class of therapies; the DPP-IV inhibitors and the GLP-1 Agonists. Considerations of incretin effects on other risk factors will be discussed. Also on the presentation agenda is the discussion of ways to support patients in overcoming the injection barrier to achieve effective management of type 2 diabetes |
May 15, 2013 | Moncton, New Brunswick |
Challenging the Hypoglycemia Care Gap
|
Type | Sponsor: Novo Nordisk | Description: This accredited continuing medical education program is offered to family physicians that have recognized a need for better screening and management of hypoglycemia in diabetic patients who are on insulin. By participating in this case based continuing medical education program you will build your skills related to events and symptoms, as well as the screening and management of hypoglycemia.
The objectives of Challenging the Hypoglycemia Care Gap are:
|
May 14,2013 | Moncton, New Brunswick |
Challenging the Hypoglycemia Care Gap
|
CME , Family MD | Sponsor: Novo Nordisk | Description This accredited continuing medical education program is offered to family physicians that have recognized a need for better screening and management of hypoglycemia in diabetic patients who are on insulin. By participating in this case based continuing medical education program you will build your skills related to events and symptoms, as well as the screening and management of hypoglycemia.
The objectives of Challenging the Hypoglycemia Care Gap are:
|
April 26,2013 | Toronto, Ontario |
“Feel IT, Try IT, Switch IT”
|
National Banner Diabetes Convention | Sponsor: BD HealthCare | This 60-minute national presentation will visit how lipohypertrophy (lipos) can adversely affect glycemic control and how proper injection technique can prevent Lipohypertrophies from developing and also by revisiting and adapting better injection techniques Lipohypertrophies can resolve resulting in better and more consistent glycemic control.
This presentation will present these 3 main topics: Feel IT
Try IT
Switch IT
The concepts will be presented using a typical insulin case presentation in a patient who has been using insulin for about 10 years. The patient has had increasing doses of insulin over the years but also has more variability of glycemic control. By investigating the impact of lipohypertrophy and then applying the FIT (Forum for Injection Technique) recommendations, the program will illustrate how as pharmacists we may help overcome the challenges of “lipo’s” by identifying poor injection technique as part of a therapy review. The role of proper needle length in avoiding intramuscular injections and its potential for causing inconsistent insulin absorption is also discussed.
|
April 11,2013 | Fredericton, New Brunswick |
Challenging the Hypoglycemia Care Gap
|
Annual Convention Mixed Health Professionals (RN,NP,PhC, RD,MD,etc) | Sponsor: Novo Nordisk | Description This accredited continuing medical education program is offered to family physicians that have recognized a need for better screening and management of hypoglycemia in diabetic patients who are on insulin. By participating in this case based continuing medical education program you will build your skills related to events and symptoms, as well as the screening and management of hypoglycemia.
The objectives of Challenging the Hypoglycemia Care Gap are:
|
April 4,2013 | Vancouver, British Columbia | “Feel IT, Try IT, Switch IT”
|
National Banner Diabetes Convention | Sponsor::BD HealthCare | This 60-minute national presentation will visit how lipohypertrophy (lipos) can adversely affect glycemic control and how proper injection technique can prevent lipohypertrophies from developing and also by revisiting and adapting better injection techniques lipohypertrophies can resolve resulting in better and more consistent glycemic control.
This presentation will present these 3 main topics: Feel IT
Try IT
Switch IT
The concepts will be presented using a typical insulin case presentation in a patient who has been using insulin for about 10 years. The patient has had increasing doses of insulin over the years but also has more variability of glycemic control. By investigating the impact of lipohypertrophy and then applying the FIT (Forum for Injection Technique) recommendations, the program will illustrate how as pharmacists we may help overcome the challenges of “lipo’s” by identifying poor injection technique as part of a therapy review. The role of proper needle length in avoiding intramuscular injections and its potential for causing inconsistent insulin absorption is also discussed.
|
March 26,2013 | Halifax, Nova Scotia |
Incretins: Addressing the Multifactorial Nature of Type 2 Diabetes
|
Local Pharmacy CME/CHE | Sponsor: Novo Nordisk | PowerPoint and case based interactive program This 60-minute presentation will visit the newer class of agents: The Incretin based therapies. The talk will explore the difference between the 2 classes of medications within this newer class of therapies; the DPP-IV inhibitors and the GLP-1 Agonists. Considerations of incretin effects on other risk factors will be discussed. Also on the presentation agenda is the discussion of ways to support patients in overcoming the injection barrier to achieve effective management of type 2 diabetes |
March 21,2013 | Saint John,
New Brunswick |
Diabetes in Pharmacy Practice
|
Local Professional CME | Sponsor: Bayer Diabetes | PowerPoint and case based interactive program, this 60-minute presentation will visit the Canadian Diabetes Association Clinical Practice Guidelines especially as they pertain to Medication management. The speaker will bring his expertise as part of the expert or writing committee of the Guidelines to the presentation, by providing some of the new and updated recommendations that are pending from the new Diabetes Guidelines to be released next month.
In addition discussions involving the new emphasis on individualizing therapy, goals, and treatments, by visiting the various criteria in determining these objectives will be presented. |
March 12, 2013 | Fredericton Junction, New Brunswick, Canada |
Managing Your Diabetes: The Journey from Metformin to Insulin
|
Local CME/Public Presentation | Sponsor: Sanofi Canada | Presentation will review the current state of Diabetes in Canada. Included is the role of the Clinical practice Guidelines from the CDA, the role of Monitoring Blood Glucose, the use of medication management and individualization of therapy goals. The early role of injection therapy is explored including the role of Basal insulin and advancing therapy with initiating mealtime insulin. |
Nov 27, 2012 | Rothesay,
New Brunswick, Canada |
Simple Steps: Starting and Intensifying Insulin in Type 2 Patients
|
Local CME | Sponsor: Novo Nordisk | PowerPoint and case based interactive program in identifying patients needing insulin therapy and also when to intensify insulin therapy |
Nov 22, 2012 | Moncton,
New Brunswick, Canada |
Simple Steps: Starting and Intensifying Insulin in Type 2 patients
|
Local Pharmacy CHE/CME | Sponsor: Novo Nordisk | PowerPoint and case based interactive program in identifying patients needing insulin therapy and also when to intensify insulin therapy |
Oct 12, 2012 | Vancouver,
British Columbia, Canada |
Diabetes Painful NEUROPATHY: A Pharmacy Case
|
National Convention | Sponsor: Pfizer | A case based presentation providing participants kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communications forms to relay information on other healthcare professionals. PowerPoint, Q&A, Interactive Case Discussion |
Oct 5, 2012 | St. John’s, Newfoundland, Canada |
Simple Steps: Starting and Intensifying Insulin in Type 2 patients
|
Local Pharmacy CHE/CME | Sponsor: Novo Nordisk | PowerPoint and care based interactive program in identifying patients needing insulin therapy and also when to intensify Insulin Therapy |
Oct 4, 2012 | St. John’s, Newfoundland, Canada |
Simple Steps: Starting and Intensifying Insulin in Type 2 patients
|
Local Pharmacy CHE/CME | Sponsor: Novo Nordisk | PowerPoint and care based interactive program in identifying patients needing insulin therapy and also when to intensify Insulin Therapy |
Oct 3, 2012 | Moncton,
New Brunswick, Canada |
Helping You to Help Your Patients With Type 2 Diabetes
|
Atlantic Aboriginal Nurses Annual Meetings | Sponsor: Merck Canada | PowerPoint presentation, lecture, Q&A, 90 minute lecture. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered. |
Sept 23, 2012 | Fredericton,
New Brunswick, Canada |
Monitoring with Purpose: Blood Glucose Pattern Management
|
Local Pharmacists CHE/CME | Sponsor: Sanofi Canada | PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. The presentation demonstrates utilizing a new tool that organizes blood glucose values to identify patterns and how to analyze and respond to these patterns. The cases include identifying when to add a second/third agent, hypoglycaemia, starting basal insulin, and using or needing to adjust diet therapy. |
July 25, 2012 | Sussex, New Brunswick, Canada |
Monitoring with Purpose: Blood Glucose Pattern Management
|
Train the Trainer | Sponsor: Sanofi Canada | PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. Provided training as a Master Trainer of the program. |
June 2, 2012 | Whistler,
British Columbia, Canada |
Are Your Patients Fit? Release of the Canadian Injection Recommendations
|
CPhA Annual General Meeting and Convention | Sponsor: Canadian Pharmacists Association CPhA | As a member of the Founding FIT Board delivered the document to the attendees and highlighted the overarching view of the printed recommendations. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and needs of special populations. |
May 31-June 1, 2012 | Whistler,
British Columbia, Canada |
Diabetes Strategy for Pharmacists
|
CPhA Annual General Meeting and Convention | Sponsor: Canadian Pharmacists Association CPhA | A 2 day 8 module overview on Diabetes and its therapies. Combination of PowerPoint, case study, hand-on workshop, and didactic learning |
May 26, 2012 | Saint John,
New Brunswick, Canada |
Are Your Patients Fit? Release of the Canadian Injection Recommendations
|
NB Pharmaceutical Society and Pharmacy Association Annual Convention | Sponsor: BD Healthcare | As a member of the Founding FIT Board delivered the document to the attendees and highlighted the overarching view of the printed recommendations. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and needs of special populations. |
May 25, 2012 | Saint John,
New Brunswick, Canada |
Diabetes Painful Neuropathy: A Pharmacy Case
|
NB Pharmaceutical Society and Pharmacy Association Annual Convention | Sponsor: Pfizer Canada | A case based presentation providing participant kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communication forms to relay information on other healthcare professionals. PowerPoint, Q&A, and interactive case discussion depending on size of group |
May 24, 2012 | Saint John,
New Brunswick, Canada |
Monitoring with Purpose: Blood Glucose Pattern Management
|
Local CHE/CME Event | Sponsor: Sanofi Canada | PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. The presentation demonstrates utilizing a new tool that organizes blood glucose values to identify patterns and how to analyze and respond to these patterns. The cases include identifying when to add a second/third agent, hypoglycaemia, starting basal insulin, and using or needing to adjust diet therapy. |
May 23, 2012 | Rexton, New Brunswick, Canada |
Integrating Incretins into Everyday Management of Diabetes
|
Luncheon CME-Physicians | Sponsor: Novo Nordisk | A PowerPoint, Q&A, and case based study on the role of Incretins in managing Type 2 Diabetes |
May 6, 2012 | Calgary. Alberta, Canada |
Diabetes Painful Neuropathy: A Pharmacy Case
|
Wal-Mart Western Pharmacists Annual Meetings | Sponsor: Pfizer Canada | A case based presentation providing participant kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communication forms to relay information on other healthcare professionals. PowerPoint, Q&A, and Interactive Care Discussion depending on the size of the group |
April 17, 2012 | Fredericton,
New Brunswick, Canada |
Are Your Patients Fit? Release of the Canadian Injection Recommendations
|
NB Diabetes Educator Sector Annual Meeting | Sponsor: BD Diabetes | As a member of the Founding FIT Board was part of the group that delivered the document to the attendees and highlighted the overarching view of the printed recommendations |
April 15, 2012 | Toronto, Ontario, Canada |
Diabetes Painful Neuropathy: A Pharmacy Case
|
Wal-Mart Eastern Pharmacists Annual Meetings | Sponsor: Pfizer Canada | A case based presentation providing participant kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communication forms to relay information on other healthcare professionals. PowerPoint, Q&A, and Interactive Care Discussion depending on the size of the group |
April 13, 2012 | Moncton,
New Brunswick, Canada |
Pattern Management
|
Local Nurse Practitioner CHE/CME | Sponsor: LifeScan Canada | PowerPoint, Q&A, Case based presentation on the use of blood glucose management to identify patterns and solutions for patients needing better glycemic control. |
March 28, 2012 | Toronto, Ontario, Canada |
Star System Launch
|
National Launch | Sponsor: Sanofi Canada | National launch of StarSystem website, provided interviews with pharmacy based media (Pharmacy practice etc.…), was present as part of the entourage of health professionals that developed and had written the material for the site |
March 22, 2012 | Fredericton,
New Brunswick, Canada |
Anaphylaxis and its Treatment: New Program Developed
|
Corporate Presentation | Sponsor: Pfizer Canada | PowerPoint and Lecture Q&A & Hands on Demo. Delivered to Maritime Pharmacy Managers in Preparation for new program on developing Adherence/Follow-up/Compliance Program on Epi-Pens etc… |
March 21, 2012 | Saint John,
New Brunswick, Canada |
Treat to Target: Insulin Therapies
|
Local CHE/CME Update | Sponsor: Sanofi Canada | PowerPoint and Lecture Q&A, Delivered to Extra Mural Nurses and via Satellite to 2 other sites. The main topic is how to progress a patient onto injection therapy including insulin therapy. Initializing basal insulin and advancing therapy onto mealtime insulin utilizing case presentations and practice tools are utilized. |
Feb 28, 2012 | Mont Tremblant, Quebec, Canada |
Star System Launch
|
Corporate Launch | Sponsor: Sanofi Canada | Was an expert advisor/presenter on material involved in developing the website accompanying the newly launched monitor. Case/real situational presentation along with Q&A as asked by the attendees |
Feb 2, 2012 | Charlottetown,
Prince Edward Island, Canada |
Forum for Injection Techniques (FIT)/ Overview of Incretins
|
Local Nurse /Nurse NP CHE/CME | Sponsor: NovoNordisk | PowerPoint and Lecture Q&A given to Prince Edward Island group of Diabetes Nurse Practitioners |
Jan 25, 2012 | Saint John,
New Brunswick, Canada |
Forum for Injection Techniques (FIT)/ Overview of Insulin 201
|
Local Nurse /Nurse NP CHE/CME | Sponsor: Sanofi Canada | PowerPoint and Lecture Q&A for Southern New Brunswick Nurse Practitioner and Pharmacists group |
Dec 14, 2011 | Saint John,
New Brunswick, Canada |
The Pharmacist’s Role in the Management of Type 2 Diabetes: Integrating GLP-1 Therapy in Diabetes Patient Care Management
|
Local Pharmacy CME/CHE | Sponsor: NovoNordisk | The topic of the newer class of Incretins, the Glucagon Like Peptide-1 (GLP-1), is explored and integrating them into the algorithm of today’s therapy was discussed. The advantages and compatibilities of this new class were discussed. PPT, Q & A, and case presentations are used to deliver the program. |
Oct 28, 2011 | Toronto, Ontario, Canada |
Are Your Patients FIT? Release of the Canadian Injection Recommendations
|
CDA/CSEM Professional Conference & Annual General Meeting | Sponsor: BD Diabetes | As a member of the founding FIT Board was part of the group that delivered the document to the attendees and highlighted the overarching view of the printed recommendations. This was the official release of the document in Canada. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and needs of special populations. |
Aug 29, 2011 | Rothesay,
New Brunswick, Canada |
Anaphylaxis and its Treatment with Epi-Pen & Twinject
|
Local School Lecture & Demonstration | Sponsor: School District 6 | Lecture and demonstration reviewing anaphylaxis signs, symptoms, causes, prevention, and hands on demonstration on how Epi-Pens are to be used. Given to Staff, Teacher Aides |
May 26-27, 2011 | Montreal, Quebec, Canada |
Diabetes Strategy for Pharmacists
|
Pre Conference Workshop | Sponsor: Canadian Pharmacists Association CPhA | A 2 day 8 module overview on Diabetes and its therapies. Combination of PowerPoint, case study, hands-on workshop, and didactic learning |
May 10, 2011 | Moncton,
New Brunswick, Canada |
Introduction to Incretins Insulin, and Injection Devices
|
Atlantic Aboriginal Diabetes Initiative | Sponsor: Health Canada | PowerPoint, Q&A, a 60 minute presentation introducing new issues on diabetes management including the new class “Incretins” and where their place in therapy will be, Glargine was approved for this population so introduction to Insulin and Insulin delivery was also presented |
May 10, 2011 | Moncton,
New Brunswick, Canada |
FIT Canada (Forum for Injection Technique)
|
Atlantic Aboriginal Diabetes Initiative | Sponsor: Health Canada | PowerPoint, Case Study, and Q&A, a 90-minute presentation on the results of the TITAN meeting and proper injection techniques. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and needs of special populations. |
April 2, 2011 | Fredericton,
New Brunswick, Canada |
Helping You to Help Your Patients With Type 2 Diabetes
|
NB Diabetes Educator Sector Annual Meeting | Sponsor: Merck Canada | PowerPoint presentation, lecture and Q&A, 90 minute lecture. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered. |
March 24, 2011 | Halifax, Nova Scotia, Canada |
Influencing Best Practice in Injection Technique
|
Local CME/CHE Pharmacists/
Nurse CDE NP |
Sponsor: BD Healthcare | Present information of the TITAN survey and the new recommendation for injection techniques to fellow health professionals. Emphasis was placed on the main messages of avoiding IM injections by assuring proper placement of insulin injections (re: needle length, proper injection technique, rotation etc. Avoiding complications) Presented minor case that was seen by presenter that recently emphasized the role of revisiting the basics that should be done periodically to optimize insulin therapy |
Feb 22, 2011 | Saint John,
New Brunswick, Canada |
Incretins: GLP-1 vs. DPP-IV, Focus on Liraglutide
|
Local CME/CHE | Sponsor: Novo Nordisk | PowerPoint presentation on the Incretin therapies covering the role that each have (GLP-1 and DPP-4) the differences between the 2 classes and focusing on the newest agent Liraglutide (a GLP analogue) and its pharmacology, expected results, where it may fall in therapy with 2 case studies included. Attended by multi disciplinary healthcare workers and teleconferenced to other remote sites with concurrent slide presentation |
Oct 20, 2010 | Edmonton, Alberta, Canada |
The View on Diabetes
|
CDA/CSEM Professional Conference and Annual Meetings | Sponsor: Sanofi Diabetes | Presented as part of multi-disciplinary healthcare team as a parody of the television show “The View”. A person with diabetes who also was a comedian; Joey Elias was moderator and all participants contributed to major topics involving issues around diabetes care from A1c, pattern management, nutrition compliance, psychological issues around diabetes, and medical management of diabetes |
June 29, 2010 | Quispamsis,
New Brunswick, Canada |
Update on Insulin & Insulin Delivery Devices
|
Local CME | Sponsor: Novo Nordisk | Original PowerPoint presentation, lecture, and Q&A covering newer insulin and injection therapies including newer delivery devices and adjusting methodology |
May 28, 2010 | Saint John,
New Brunswick, Canada |
Helping You to Help Your Patients With Type 2 Diabetes
|
NB Pharmacists Association Annual Conference & Trade Show | Sponsor: Merck Canada | PowerPoint presentation, lecture and Q&A, 90 minute lecture. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered. |
May 16-18, 2010 | Calgary, Alberta, Canada |
Insulin Pump Therapy: Just the Basics
|
CPA Annual National Conference & Trade Show | Sponsor: Canadian Pharmacists Association CPhA | An original program developed to provide as described the basics of pump therapy from theory of pump therapy, language of pump therapy, who is a good candidate, advantages of pump therapy, supplies and how the system is put together, costs, insurances, and how we determine initial doses for basal and bolus rates, other areas discussed. Provided two “Hands-on” sessions, 90 minutes each |
May 14-15,2010 | Calgary, Alberta, Canada |
Diabetes Workshop: The How to of Managing Diabetes… A Prescription of Pharmacists
|
CPA Annual National Conference & Trade Show | Sponsor: Canadian Pharmacists Association CPhA | As Canadian Diabetes Champion for Pharmacists: co-delivered a 2-day, 9-hour workshop on the role of Pharmacists in Diabetes care. Session was a combination of PowerPoint, Hands-on, workshop, interaction |
April 29-30, 2010 | Saint John’s Newfoundland, Canada |
Helping You to Help Your Patients With Type 2 Diabetes
|
Provincial DES Conference | Sponsor: Merck Canada | 90 minute PowerPoint presentation, lecture and Q&A provided as a keynote presentation to the provincial DES annual meeting. Audience was mostly Hospital & Clinical Diabetes Educators including registered Nurses, Dieticians, Pharmacists and other allied Health Care Workers |
April 14, 2010 | Rothesay,
New Brunswick, Canada |
Circadian Rhythm of Blood Pressure: Implications for Clinical Practice
|
Local CHE/CME | Sponsor: BioVail | PowerPoint Presentation, discussion, and Q&A on chronotherapy and novel drug delivery systems and how they may improve control by utilizing new technology. |
March 26, 2010 | Fredericton,
New Brunswick, Canada |
Helping You to Help Your Patients With Type-2 Diabetes
|
NB Diabetes Educator Sector Annual Meeting | Sponsor: Merck Canada | Acted as facilitator for opening session and provided abbreviated version of above program on day 2 of convention |
Feb 25, 2010 | Saint John,
New Brunswick, Canada |
A Review of Medications & an Update on New Devices
|
Local CME
Multidisciplinary Health Professions |
Sponsor: Lilly Canada | PowerPoint Presentation, discussion and Q&A on what is new in medications for diabetes (Incretins, etc.) as well as what is new for devices including Contour USB meter and other new devices |
Feb 21, 2010 | Sudbury, Ontario, Canada |
Diabetes Workshop: The How to of Managing Diabetes… A Prescription of Pharmacists
|
Pharmacy based CME/CHE | Sponsor: Canadian Pharmacists Association CPhA | As Canadian Diabetes Champion for Pharmacists: co-delivered a 2-day, 9-hour workshop on the role of Pharmacists in Diabetes care. Session was a combination of PowerPoint, Hands-on, workshop, interaction |
Jan 31, 2010 | Toronto, Ontario, Canada |
Helping You to Help Your Patients With Type 2 Diabetes
|
Canadian Society of Hospital Pharmacists: Professional Conference | Sponsor: IntraMed Group/Merck Canada | Satellite session to Professional Practice Conference 90 minute lecture PowerPoint, Q&A to audience of Hospital and Clinical Pharmacists. This was the official launch of the program. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered. |
Jan 12, 2010 | Quebec City, Quebec, Canada |
The 5 Minute Manager
|
Abbott Diabetes Care Team AGM | Sponsor: Abbott Diabetes Care | Presentation of a new program including “Start Right, Right Away”. Included tools, Discussion Q&A, and PowerPoint presentation. Presented to mainly Diabetes Sales Force and Executives of Abbott Diabetes Care |
Nov 18, 2009 | Saint John,
New Brunswick, Canada |
Diabetes Care Update and Insulin Pump Introduction
|
Long Term Care Workers | Sponsor: Lawtons Drugs | PowerPoint, Lecture, Q&A Session, personally hooked up to an insulin pump to demonstrate the various parts, its functionality, use, and review the pump supplies (i.e. reservoirs, infusion sets, insertion devices, etc.) A general review of diabetes medication management also was provided to position where insulin is used and then identifying who may be a good candidate to use the insulin pump. |
May 31, 2008 | Miramichi,
New Brunswick, Canada |
Medication: It’s Not Always About Your Blood Sugars
|
Canadian Diabetes Expo | Sponsor: Canadian Diabetes Association | PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered Dieticians, Industry Reps, People with Diabetes, Canadian Diabetes Association Representatives about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices. |
April 17, 2008 | Moncton,
New Brunswick, Canada |
Update on Diabetes Medications & Treatments
|
CHE, CME Evening Session | Sponsor: Sanofi Canada | PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered dieticians, pharmacists, industry reps about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices. Emphasis placed on the role of insulin and long acting analogue insulin and its impact on therapy was provided. |
April 4, 2008 | Fredericton,
New Brunswick, Canada |
Medications: Trials & Tribulations
|
Provincial Convention | Sponsor: Diabetes Educator Sector | PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered dieticians, EMH staff, Nurse practitioners, and physicians about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices. Also included were the various medications used to manage the co-morbidities associated with diabetes (CVD- cholesterol, blood pressure, kidney protection) |
Nov 28, 2007 | Saint John,
New Brunswick, Canada |
Long Acting Insulin Analogues: Focus on Glargine
|
Extra Mural Nurses | Sponsor: Sanofi Canada | PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered Dieticians, EMH staff on insulin Glargine. Its advantages over insulin NPH, how to switch from NPH insulin, dosages, and reviewed the devices used to deliver Glargine. |
Nov 20, 2007 | Saint John,
New Brunswick, Canada |
Signature Speaker Series: Diabetes: What You Need to Know
|
Public Presentation | Sponsor: Canadian Diabetes Association | PowerPoint, Lecture, Q&A provided to the T.O.P.S. on the basics of what diabetes is, its prevalence, its symptoms and it management. |
Nov 9, 2007 | Moncton,
New Brunswick, Canada |
Targeting Patient Needs when Treating & Managing Diabetes
|
Multi Disciplinary
CHE/CME |
Sponsor: GSK Prisme-Diabetes Program | PowerPoint, Lecture, Q&A Discussion provided about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices. Emphasis placed on the role of insulin and long acting analogue insulin and its impact on therapy was provided. Program included “breakout sessions” for more targeted presentations to specific health professional groups |
Oct 27, 2007 | Vancouver,
British Columbia, Canada |
Establishing a Pharmacist/CDE Practice within a Retail Pharmacy Setting
|
CDA/CSEM Professional Conference and Meetings | Sponsor: Canadian Diabetes Association | PowerPoint, Lecture, Q&A Discussion provided during the Pharmacy Symposium on the evolving role of the pharmacist in the collaborative care of the person with diabetes. Areas emphasized included general medication management and the role of the pharmacist in initializing insulin therapy and the role in adjusting insulin therapy |
Oct 11, 2007 | Charlottetown,
Prince Edward Island, Canada |
Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!
|
Pharmacy based CME | Sponsor: Roche Diagnostics | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes |
Oct 10, 2007 | Saint John,
New Brunswick, Canada |
Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!
|
Pharmacy based CME | Sponsor: Roche Diagnostics | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes |
Oct 4, 2007 | Moncton,
New Brunswick, Canada |
Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!
|
Pharmacy based CME | Sponsor: Roche Diagnostics | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy TechniciansPowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes |
Oct 3, 2007 | Fredericton,
New Brunswick, Canada |
Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!
|
Pharmacy based CME | Sponsor: Roche Diagnostics | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy TechniciansPowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes |
June 27, 2007 | Moncton,
New Brunswick, Canada |
The Art of Diabetes Education & Care
|
Multidisciplinary
CME/CHE |
Sponsor: Eli-Lilly Canada | Moderated and Facilitated Presentation by Kris Swenson of the Diabetes University, Phoenix, Arizona. Acted as co-presenter in a generalized talk “The Art of Diabetes Education and Care”. |
June 21, 2007 | Rothesay,
New Brunswick, Canada |
S.M.A.R.T. Therapy: A New Paradigm in Asthma Therapy
|
Pharmacy CME | Sponsor: AstraZeneca | Introduced new concept in approaching Asthma therapy and where it may fit in Treatment Continuums |
June 9-10, 2007 | Brudnell Resort,
Prince Edward Island, Canada |
Advances in Pharmaceutical Science & New Horizons in Pharmacotherapy
|
Family Medicine
CHE |
Sponsor: BioVail | Provided six 1-hour sessions on above topic to Family Practitioners and Specialists. Topic involved in new delivery systems and how it may benefit medication management by improving the method of drug delivery |
June 1, 2007 | Saint John,
New Brunswick, Canada |
Ask the Expert
|
New Brunswick Dental Association Annual General Meeting | Sponsor: Canadian Diabetes Association | Available to convention attendees to answer questions involving Diabetes and issues surrounding the “Metabolic Syndrome”. Provided screening for blood glucose results as well as total cholesterol readings and information on different treatment modalities. |
May 9, 2007 | Saint John,
New Brunswick, Canada |
Optimizing Diabetes Care
|
Pharmacists/ Pharmacy CME/CHE | Sponsor: Bayer Healthcare | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists/ Pharmacy Technicians. Topics included the CDA CPG Guidelines and its goals for therapies. The role of the technician and helping choose the proper monitor. The use of monitoring in the role of adjusting medications was discussed. The role of the collaborative team in managing diabetes and how these roles can be identified and enhanced by better interaction was delivered. |
May 7, 2007 | Saint John,
New Brunswick |
Ask the Expert
|
Health Fair/Public Presentation | Sponsor: Pfizer Canada | Available to attendees to answer questions involving Diabetes and issues surrounding the “Metabolic Syndrome”. Part of expert panel with Dietician and nurse CDE. Components of the metabolic syndrome were discussed as well as screening was provided to willing participants to emphasize which target values we are screening for. |
Dec 6, 2006 | Saint John,
New Brunswick, Canada |
Self Monitoring of Blood Glucose You Don’t Have to be UltraSmart to use the UltraSmart Meter
|
Pharmacists/ Pharmacy Technicians | Sponsor: LifeScan Canada | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values |
Nov 20, 2006 | Moncton,
New Brunswick, Canada |
Self Monitoring of Blood Glucose You Don’t Have to be UltraSmart to use the UltraSmart Meter
|
Pharmacists/ Pharmacy Technicians | Sponsor: LifeScan Canada | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values |
Nov 14, 2006 | Fredericton,
New Brunswick, Canada |
Self Monitoring of Blood Glucose You Don’t Have to be UltraSmart to use the UltraSmart Meter
|
Pharmacists/ Pharmacy Technicians | Sponsor: LifeScan Canada | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values |
Nov 2, 2006 | Saint John,
New Brunswick, Canada |
Self Monitoring of Blood Glucose You Don’t Have to be UltraSmart to use the UltraSmart Meter
|
Pharmacists/ Pharmacy Technicians | Sponsor: LifeScan Canada | PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values |
Nov 2, 2006 | Saint John,
New Brunswick, Canada |
Chronotherapy, Glumetza and it’s Role in Treatment of Diabetes
|
Multidisciplinary CME/CHE | Sponsor: BioVail Pharmaceuticals | PowerPoint, Lecture provided to Diabetic Educators. Involved with patient care within the Clinical setting. Emphasis on new delivery technology and how it can positively impact patient outcomes and reduce side effects was discussed. The role of timed delivery to maximize medication effect was also explored. |
Oct 11, 2006 | Rothesay,
New Brunswick, Canada |
Anaphylaxis and its Treatment with EpiPen and Twinject
|
School Staff Presentation | Sponsor: Kennebecasis Drugs Ltd. | Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Oct 5, 2006 | Rothesay,
New Brunswick, Canada |
Anaphylaxis and its Treatment with EpiPen and Twinject
|
School Staff Presentation | Sponsor: Kennebecasis Drugs Ltd. | Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Sept 28, 2006 | Rothesay,
New Brunswick, Canada |
Anaphylaxis and its Treatment with EpiPen and TwinJect Device
|
School Staff Presentation | Sponsor: Kennebecasis Drugs Ltd. | In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Sept 27, 2006 | Truro, Nova Scotia, Canada |
Insulin Pump Therapy 101: Just the Basics
|
Multidisciplinary CME/CHE | Sponsor: Sanofi Canada | PowerPoint, Lecture provided to Educators, Physicians and Dietician of Cumberland County. Reviewed role of insulin and provided background information on Insulin Pumps and their therapies. Discussed advanced features, demonstrated real time Glucose Monitoring by wearing a monitor. Discussed what is in the future for monitoring and the future of Insulin Pumps |
Sept 25, 2006 | Saint John,
New Brunswick, Canada |
Long Acting Analogues: One Year Later
|
Diabetes Educator Sector Meeting | Sponsor: Sanofi | PowerPoint presentation given to Certified Diabetic Educators, Pharmacists, Dieticians etc. Review of insulin therapies, role of long acting insulin, advantages of the new long acting analogues, have they lived up to the hype? |
Aug 23, 2006 | Moncton,
New Brunswick, Canada |
Creating Diabetes Magic
|
Multidisciplinary CME/CHE | Sponsor: Eli Lilly Canada | Acted as moderator/host for the program given by Kris Swenson (RN CDE Diabetes Management & Training Centers Inc.) |
June 12, 2006 | Saint John,
New Brunswick, Canada |
What You Need to Know About Diabetes
|
Administrative Executive Program (NBCC) | Sponsor: Canadian Diabetes Association | PowerPoint, Lecture covering Diabetes in the workplace and what can be done for prevention and screening to identify people at risk. Symptoms and signs of diabetes were reviewed, along with prevalence and various general topics around diabetes were presented for discussion |
June 8, 2006 | Saint John,
New Brunswick, Canada |
Simplified: Starting Insulin & Managing Patients
|
Type | Sponsor: NovoNordisk | PowerPoint presentation establishing the case for insulin therapy, discussed the initiation of insulin therapies, including new long acting analogues and concerns of initiating insulin. Comparisons of the delivery devices were also provided. |
May 13, 2006 | Fredericton,
New Brunswick, Canada |
From Pills to the Gila Monster: How We Treat Your Diabetes
|
CDA Annual Meeting (New Brunswick Branch) | Sponsor: Canadian Diabetes Association | Presentation given to the annual meeting of the Canadian Diabetes Association (CDA) New Brunswick Branch. Lecture reviewing statistics of Diabetes, and treatment from past, present and what is up and coming for the future |
May 12, 2006 | Saint John,
New Brunswick, Canada |
Medication & Diabetes: Establishing The Foundation
|
Nurse Practitioner Annual Meeting/ CME | Sponsor: AstraZeneca | Presentation involved the basis of why medications are needed for the treatment of Diabetes, and treatment of comorbidities (ACE therapy, ASA therapy, Statins etc.). The emphasis on interactions and proper dosing was presented. |
March 22, 2006 | Quispamsis,
New Brunswick, Canada |
Diabetes Survival: Things You Need To Know
|
Public Presentation | Sponsor: Canadian Diabetes Association | PowerPoint, Handouts, Q&A used to cover “Survival Techniques” as if someone had been newly diagnosed with Diabetes. |
March 21, 2006 | Saint John,
New Brunswick, Canada |
Diabetes Awareness
|
Public Presentation | Sponsor: University of New Brunswick | Presentation of “What is diabetes, the prevention of Diabetes, and how to live well with Diabetes” |
Feb 7, 2006 | Saint John,
New Brunswick, Canada |
Blood Glucose Monitoring: Just the Basics
|
Family Medicine CHE | Sponsor: Roche Pharmaceuticals | Presentation given about the need to test Blood Glucose and its importance to your patients, roundtable discussion on related topics involving monitoring issues and procedures was provided. |
Dec 1, 2005 | Saint John,
New Brunswick, Canada |
Continuity of Care: From Diabetes Teaching to Your Counter
|
Pharmacy CME | Sponsor: GlaxoSmithKline | Presentation involving the methods and programs used at the Diabetes Education Centre (DEC) , reviewed the 2003 Guidelines, discussed the role of the TZD in treatment of Diabetes |
Nov 29, 2005 | Hampton,
New Brunswick, Canada |
Diabetes Awareness Night
|
Public Presentation | Sponsor: Saint John Regional Hospital | Presentation given about Diabetes and the seriousness of the disease. The presentation was part of a multidisciplinary panel each providing a session on their specialty- nursing, dieticians, pharmacy |
Nov 7, 2005 | Saint John,
New Brunswick, Canada |
Update from the Canadian Diabetes Association Annual Meeting, Edmonton Alberta
|
Diabetes Educator Fall Meeting | Sponsor: Diabetes Educator Sector | In-service to the Diabetes Educator Sector Region 2 Fall meeting on programs attended at the above Annual Meeting. |
Oct 5, 2005 | Rothesay,
New Brunswick, Canada |
Anaphylaxis and its Treatment with EpiPen and TwinJect Device
|
School Staff Presentation | Sponsor: New Brunswick School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Sept 29, 2005 | Quispamsis,
New Brunswick, Canada |
Anaphylaxis and its Treatment with EpiPen Device
|
School Staff Presentation | Sponsor: New Brunswick School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Sept 28, 2005 | Quispamsis,
New Brunswick, Canada |
Anaphylaxis and its Treatment with EpiPen Device
|
School Staff Presentation | Sponsor: New Brunswick School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Sept 20, 2005 | Rothesay,
New Brunswick, Canada |
Anaphylaxis and its Treatment with EpiPen Device
|
School Staff Presentation | Sponsor: New Brunswick School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
March 21, 2005 | Rothesay,
New Brunswick, Canada |
Lantus Insulin & Welcome to Diabetes
|
Multidisciplinary CME/CHE | Sponsor: Sanofi Canada | Presentation of a new insulin to the group, an expanded version of “Welcome to Diabetes” with more emphasis on listening techniques and interaction with the audience. |
Nov 25, 2004 | Saint John,
New Brunswick, Canada |
Achieving Diabetes Control with Optimal Blood Glucose Monitoring
|
Pharmacy CME | Sponsor: Bayer Healthcare | Presentation involving the role of self-monitoring of blood glucose in the management of Diabetes |
Nov 3, 2004 | Fredericton, New Brunswick, Canada |
Welcome to Diabetes Best Practices Initiatives
|
Multidisciplinary CHE/CME | Sponsor: CADTH | Presented “Best Practices Initiatives” during meetings of COMPUS (Canadian Optimal Medication Prescribing & Utilization Service) a new program provided by CCOHTA (Canadian Coordinating Office for Heath Technology Assessment) |
April 22, 2004 | Saint John,
New Brunswick, Canada |
Sense of Urgency in Asthma Treatment
|
Pharmacy CME | Sponsor: GlaxoSmithKline | Facilitated discussion on Asthma guidelines, Pharmacy intervention, role of Pharmacist, use of tools, dangers of undertreated Asthma |
Feb 25,2004 | Quispamsis,
New Brunswick, Canada |
Smoking Cessation
|
General Public Presentation | Sponsor: Kennebecasis Drugs Ltd. | Prepared & Presented presentation and Q&A session to provide information for students looking to quit smoking. |
Nov 4, 2003 | Saint John,
New Brunswick, Canada |
Arthritis Overview and Treatments
|
General Public Presentation | Sponsor: Pfizer Canada | Prepared & Presented presentation and Q&A session involving various arthritis treatments and Over-the-counter products used in the treatment of arthritis |
Nov 13, 2002 | Rothesay,
New Brunswick, Canada |
A Night of Women’s Health Issues
|
General Public Presentations | Sponsor: Kennebecasis Drugs Ltd. | Acted as facilitator and mater of ceremonies covering a number of topics involving women’s issues and natural treatments to help relieve these issues. |
Nov 29, 2002 | Hampton,
New Brunswick, Canada |
OTC’s & Prescription Medications and Their Effect on Alertness
|
School District Employee General Education | Sponsor: Kennebecasis Drugs Ltd | Prepared and delivered a 60-minute session on the effects of prescription medications and over-the-counter medications may have on alertness and performance. Emphasis was for bus drivers and personal care workers or educational assistants who are directly responsible for childcare. |
Sept 24, 2002 | Rothesay,
New Brunswick, Canada |
Symptoms & Treatment of Anaphylaxis & EpiPen
|
School Staff Presentation | Sponsor: School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Feb 22, 2002 | Rothesay,
New Brunswick, Canada |
Pharmacist Bob’s Traveling Drug Show
|
School student Presentation | Sponsor: Rob Roscoe (to become R-2 Consulting) | An award winning presentation involving a variety of topics including “good” vs. “bad” drugs using a board with candy vs. drug demonstration, what a pharmacist does, nicotine & alcohol as drugs, etc. |
Oct 15, 2001 | Rothesay, New Brunswick, Canada |
Symptoms & Treatment of Anaphylaxis & EpiPen
|
School staff presentation | Sponsor: School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Fall 2000 | Saint John,
New Brunswick, Canada |
Symptoms & Treatment of Anaphylaxis & EpiPen
|
School Staff Presentation/ BUS Drivers | Sponsor: School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
Fall 2000 | Hampton,
New Brunswick, Canada |
Symptoms & Treatment of Anaphylaxis & EpiPen
|
School Staff Presentation/ Bus Drivers | Sponsor: School District | Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario. |
June 13, 2000 | Fredericton, New Brunswick, Canada |
Smoking Cessation
|
New Brunswick Pharmacy Conference | Sponsor: Glaxo/Wellcome | Description |
Nov 19, 1999 | Saint John, New Brunswick, Canada |
Smoking Cessation
|
Type | Sponsor: Glaxo/Wellcome | Description |
Oct 1999 | Bathurst, New Brunswick, Canada |
Smoking Cessation
|
Type | Sponsor: Hoescht Pharmaceuticals | Description |
May 7, 1999 | Fredericton, New Brunswick, Canada |
New Smoking Cessation Medications and Nicotine Replacement Therapies: Their Role in Smoking Cessation
|
Type | Sponsor: Glaxo/Wellcome | Description |
Nov 19, 1998 | Moncton, New Brunswick, Canada |
Helping Your Patient Quit Smoking: The Pharmacist as Key Partner
|
Continuing Education Session | Sponsor: Glaxo/Wellcome | Description |
Nov 17, 1998 | Saint John, New Brunswick, Canada |
Helping Your Patient Quit Smoking: The Pharmacist as Key Partner
|
Continuing Education Session | Sponsor: Glaxo/Wellcome | Description |
Fall 1998 | Rothesay, New Brunswick, Canada |
Safe Use of EpiPens and Management of Allergic Reactions
|
Type | Description |
Fall 1998 | Quispamsis, New Brunswick, Canada |
Safe Use of EpiPens and Management of Allergic Reactions
|
Type | Description |
Spring 1998 | Kennebecasis Valley, New Brunswick, Canada |
Safe Use of EpiPens and Management of Allergic Reactions
|
Type | Description |
Oct 16, 1996 | Quispamsis, New Brunswick, Canada |
Depression: A Community Perspective
|
Type | Sponsor: Eli Lilly & Canadian Mental Health | Description |
Nov 15, 1985 | Fredericton, New Brunswick, Canada |
Breast Cancer Treatments
|
Type | Sponsor: Merck Canada | Description |
Date | Location |
Title
|
Type | Sponsor | Description |
Location |
Title
|
|
Type | Sponsor | Description |
Date | Location |
Title
|
Type | Sponsor | Description |
Date | Location |
Title
|
Type | Sponsor | Description |
Date | Location |
Title
|
Type | Sponsor | Description |
Date | Location |
Title
|
Type | Sponsor | Description |
Date | Location |
Title
|
Type | Sponsor | Description |
Date | Location |
Title
|
Type | Sponsor | Description |
Date | Location |
Title
|
Type | Sponsor | Description |